{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T06:33:07Z","timestamp":1780986787096,"version":"3.54.1"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000053","name":"U.S. Department of Health & Human Services | NIH | National Eye Institute","doi-asserted-by":"publisher","award":["R21EY033046"],"award-info":[{"award-number":["R21EY033046"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-024-07394-w","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T07:51:32Z","timestamp":1736409092000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Systemic regulation of retinal medium-chain fatty acid oxidation repletes TCA cycle flux in oxygen-induced retinopathy"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6938-8072","authenticated-orcid":false,"given":"Almut","family":"Heinken","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7450-2589","authenticated-orcid":false,"given":"John M.","family":"Asara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopalan","family":"Gnanaguru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4015-0591","authenticated-orcid":false,"given":"Charandeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,9]]},"reference":[{"key":"7394_CR1","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.clp.2013.02.002","volume":"40","author":"LE Smith","year":"2013","unstructured":"Smith, L. E., Hard, A. L. & Hellstr\u00f6m, A. The biology of retinopathy of prematurity: how knowledge of pathogenesis guides treatment. Clin. Perinatol. 40, 201\u2013214 (2013).","journal-title":"Clin. Perinatol."},{"key":"7394_CR2","doi-asserted-by":"crossref","unstructured":"Singh, C. et al. Serine and 1-carbon metabolism are required for HIF-mediated protection against retinopathy of prematurity. JCI Insight 4, e129398 (2019).","DOI":"10.1172\/jci.insight.129398"},{"key":"7394_CR3","doi-asserted-by":"publisher","first-page":"19898","DOI":"10.1073\/pnas.0805817105","volume":"105","author":"JE Sears","year":"2008","unstructured":"Sears, J. E., Hoppe, G., Ebrahem, Q. & Anand-Apte, B. Prolyl hydroxylase inhibition during hyperoxia prevents oxygen-induced retinopathy. Proc. Natl Acad. Sci. USA 105, 19898\u201319903 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"7394_CR4","doi-asserted-by":"crossref","unstructured":"Giusto, K., Wanczyk, H., Jensen, T. & Finck, C. Hyperoxia-induced bronchopulmonary dysplasia: better models for better therapies. Dis. Model Mech. 14, dmm047753 (2021).","DOI":"10.1242\/dmm.047753"},{"key":"7394_CR5","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1002\/hep.32540","volume":"76","author":"C Amadou","year":"2022","unstructured":"Amadou, C. et al. Association between birth weight, preterm birth, and nonalcoholic fatty liver disease in a community-based cohort. Hepatology 76, 1438\u20131451 (2022).","journal-title":"Hepatology"},{"key":"7394_CR6","doi-asserted-by":"publisher","first-page":"903","DOI":"10.3390\/diagnostics12040903","volume":"12","author":"C Singh","year":"2022","unstructured":"Singh, C. Metabolism and Vascular Retinopathies: Current Perspectives and Future Directions. Diagnostics 12, 903 (2022).","journal-title":"Diagnostics"},{"key":"7394_CR7","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1001\/archophthalmol.2012.592","volume":"130","author":"J Hu","year":"2012","unstructured":"Hu, J. et al. Reactivation of retinopathy of prematurity after bevacizumab injection. Arch. Ophthalmol. 130, 1000\u20131006 (2012).","journal-title":"Arch. Ophthalmol."},{"key":"7394_CR8","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1016\/j.ophtha.2016.04.028","volume":"123","author":"HA Mintz-Hittner","year":"2016","unstructured":"Mintz-Hittner, H. A., Geloneck, M. M. & Chuang, A. Z. Clinical Management of Recurrent Retinopathy of Prematurity after Intravitreal Bevacizumab Monotherapy. Ophthalmology 123, 1845\u20131855 (2016).","journal-title":"Ophthalmology"},{"key":"7394_CR9","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1097\/IAE.0000000000002663","volume":"40","author":"KP Ling","year":"2020","unstructured":"Ling, K. P. et al. Rates and risk factors for recurrence of retinopathy of prematurity after laser or intravitreal anti-vascular endothelial growth factor monotherapy. Retina 40, 1793\u20131803 (2020).","journal-title":"Retina"},{"key":"7394_CR10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/17469899.2019.1596026","volume":"14","author":"ED Hansen","year":"2019","unstructured":"Hansen, E. D. & Hartnett, M. E. A review of treatment for retinopathy of prematurity. Expert Rev. Ophthalmol. 14, 73\u201387 (2019).","journal-title":"Expert Rev. Ophthalmol."},{"key":"7394_CR11","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s10522-008-9134-x","volume":"9","author":"H Unterluggauer","year":"2008","unstructured":"Unterluggauer, H. et al. Premature senescence of human endothelial cells induced by inhibition of glutaminase. Biogerontology 9, 247\u2013259 (2008).","journal-title":"Biogerontology"},{"key":"7394_CR12","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1161\/CIRCRESAHA.116.302855","volume":"116","author":"G Eelen","year":"2015","unstructured":"Eelen, G., de Zeeuw, P., Simons, M. & Carmeliet, P. Endothelial cell metabolism in normal and diseased vasculature. Circ. Res. 116, 1231\u20131244 (2015).","journal-title":"Circ. Res."},{"key":"7394_CR13","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.15252\/embj.201796436","volume":"36","author":"B Kim","year":"2017","unstructured":"Kim, B., Li, J., Jang, C. & Arany, Z. Glutamine fuels proliferation but not migration of endothelial cells. EMBO J. 36, 2321\u20132333 (2017).","journal-title":"EMBO J."},{"key":"7394_CR14","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.73105","volume":"11","author":"Z Wang","year":"2022","unstructured":"Wang, Z. et al. Amino acid transporter SLC38A5 regulates developmental and pathological retinal angiogenesis. eLife 11, e73105 (2022).","journal-title":"eLife"},{"key":"7394_CR15","doi-asserted-by":"publisher","first-page":"e1075","DOI":"10.1038\/cddis.2014.23","volume":"5","author":"SP Narayanan","year":"2014","unstructured":"Narayanan, S. P. et al. Arginase 2 deficiency reduces hyperoxia-mediated retinal neurodegeneration through the regulation of polyamine metabolism. Cell Death Dis. 5, e1075 (2014).","journal-title":"Cell Death Dis."},{"key":"7394_CR16","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3390\/life11070614","volume":"11","author":"C Singh","year":"2021","unstructured":"Singh, C. et al. Hyperoxia Inhibits Proliferation of Retinal Endothelial Cells in a Myc-Dependent Manner. Life 11, 614 (2021).","journal-title":"Life"},{"key":"7394_CR17","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/nyas.12956","volume":"1363","author":"SJ Mentch","year":"2016","unstructured":"Mentch, S. J. & Locasale, J. W. One-carbon metabolism and epigenetics: understanding the specificity. Ann. N. Y. Acad. Sci. 1363, 91\u201398 (2016).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"7394_CR18","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1002\/iub.230","volume":"61","author":"AE Pegg","year":"2009","unstructured":"Pegg, A. E. Mammalian polyamine metabolism and function. IUBMB Life 61, 880\u2013894 (2009).","journal-title":"IUBMB Life"},{"key":"7394_CR19","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jnutbio.2019.05.010","volume":"70","author":"DAA de Vasconcelos","year":"2019","unstructured":"de Vasconcelos, D. A. A. et al. Oral L-glutamine pretreatment attenuates skeletal muscle atrophy induced by 24-h fasting in mice. J. Nutritional Biochem. 70, 202\u2013214 (2019).","journal-title":"J. Nutritional Biochem."},{"key":"7394_CR20","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s11306-011-0293-4","volume":"8","author":"W R\u00f6misch-Margl","year":"2012","unstructured":"R\u00f6misch-Margl, W. et al. Procedure for tissue sample preparation and metabolite extraction for high-throughput targeted metabolomics. Metabolomics 8, 133\u2013142 (2012).","journal-title":"Metabolomics"},{"key":"7394_CR21","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.tiv.2010.03.016","volume":"24","author":"J van der Valk","year":"2010","unstructured":"van der Valk, J. et al. Optimization of chemically defined cell culture media \u2013 Replacing fetal bovine serum in mammalian in vitro methods. Toxicol. Vitr. 24, 1053\u20131063 (2010).","journal-title":"Toxicol. Vitr."},{"key":"7394_CR22","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1159\/000242739","volume":"52","author":"M Hamosh","year":"1987","unstructured":"Hamosh, M. Lipid metabolism in premature infants. Biol. Neonate 52, 50\u201364 (1987).","journal-title":"Biol. Neonate"},{"key":"7394_CR23","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1093\/ajcn\/38.2.300","volume":"38","author":"J Bitman","year":"1983","unstructured":"Bitman, J., Wood, L., Hamosh, M., Hamosh, P. & Mehta, N. R. Comparison of the lipid composition of breast milk from mothers of term and preterm infants. Am. J. Clin. Nutr. 38, 300\u2013312 (1983).","journal-title":"Am. J. Clin. Nutr."},{"key":"7394_CR24","doi-asserted-by":"publisher","first-page":"G287","DOI":"10.1152\/ajpgi.00105.2023","volume":"325","author":"AS Pereyra","year":"2023","unstructured":"Pereyra, A. S., McLaughlin, K. L., Buddo, K. A. & Ellis, J. M. Medium-chain fatty acid oxidation is independent of l-carnitine in liver and kidney but not in heart and skeletal muscle. Am. J. Physiol. Gastrointest. Liver Physiol. 325, G287\u2013g294 (2023).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"7394_CR25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/cld.865","volume":"15","author":"SR Send","year":"2020","unstructured":"Send, S. R. Nutritional Management of Cholestasis. Clin. Liver Dis. 15, 9\u201312 (2020).","journal-title":"Clin. Liver Dis."},{"key":"7394_CR26","doi-asserted-by":"crossref","unstructured":"Lester, R. Bile acid metabolism in the fetus and newborn. Ciba Found Symp., 70, 99\u2013115 (1979).","DOI":"10.1002\/9780470720530.ch6"},{"key":"7394_CR27","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s10456-023-09872-x","volume":"26","author":"Z Fu","year":"2023","unstructured":"Fu, Z. et al. FGF21 via mitochondrial lipid oxidation promotes physiological vascularization in a mouse model of Phase I ROP. Angiogenesis 26, 409\u2013421 (2023).","journal-title":"Angiogenesis"},{"key":"7394_CR28","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.1172\/JCI29683","volume":"116","author":"MR Ritter","year":"2006","unstructured":"Ritter, M. R. et al. Myeloid progenitors differentiate into microglia and promote vascular repair in a model of ischemic retinopathy. J. Clin. Invest. 116, 3266\u20133276 (2006).","journal-title":"J. Clin. Invest."},{"key":"7394_CR29","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1167\/iovs.06-0531","volume":"48","author":"P van Wijngaarden","year":"2007","unstructured":"van Wijngaarden, P., Brereton, H. M., Coster, D. J. & Williams, K. A. Genetic influences on susceptibility to oxygen-induced retinopathy. Invest. Ophthalmol. Vis. Sci. 48, 1761\u20131766 (2007).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"7394_CR30","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.exer.2007.07.001","volume":"85","author":"P van Wijngaarden","year":"2007","unstructured":"van Wijngaarden, P., Brereton, H. M., Gibbins, I. L., Coster, D. J. & Williams, K. A. Kinetics of strain-dependent differential gene expression in oxygen-induced retinopathy in the rat. Exp. Eye Res. 85, 508\u2013517 (2007).","journal-title":"Exp. Eye Res."},{"key":"7394_CR31","first-page":"377","volume":"18","author":"BE O\u2019Bryhim","year":"2012","unstructured":"O\u2019Bryhim, B. E., Radel, J., Macdonald, S. J. & Symons, R. C. The genetic control of avascular area in mouse oxygen-induced retinopathy. Mol. Vis. 18, 377\u2013389 (2012).","journal-title":"Mol. Vis."},{"key":"7394_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15066-6","volume":"11","author":"C Singh","year":"2020","unstructured":"Singh, C. et al. Hyperoxia induces glutamine-fuelled anaplerosis in retinal M\u00fcller cells. Nat. Commun. 11, 1277 (2020).","journal-title":"Nat. Commun."},{"key":"7394_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-11-315","volume":"11","author":"GD Maurer","year":"2011","unstructured":"Maurer, G. D. et al. Differential utilization of ketone bodies by neurons and glioma cell lines: a rationale for ketogenic diet as experimental glioma therapy. BMC Cancer 11, 315 (2011).","journal-title":"BMC Cancer"},{"key":"7394_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2023.148324","volume":"1808","author":"Y-S Zhuang","year":"2023","unstructured":"Zhuang, Y.-S. et al. Neuroprotective mechanisms of OXCT1 via the SIRT3-SOD2 pathway after traumatic brain injury. Brain Res. 1808, 148324 (2023).","journal-title":"Brain Res."},{"key":"7394_CR35","doi-asserted-by":"publisher","first-page":"6419","DOI":"10.1167\/iovs.17-21931","volume":"58","author":"M Holm","year":"2017","unstructured":"Holm, M. et al. Systemic Inflammation-Associated Proteins and Retinopathy of Prematurity in Infants Born Before the 28th Week of Gestation. Invest. Ophthalmol. Vis. Sci. 58, 6419\u20136428 (2017).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"7394_CR36","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1159\/000087587","volume":"88","author":"LE Smith","year":"2005","unstructured":"Smith, L. E. IGF-1 and retinopathy of prematurity in the preterm infant. Biol. Neonate 88, 237\u2013244 (2005).","journal-title":"Biol. Neonate"},{"key":"7394_CR37","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1111\/apm.12223","volume":"122","author":"H Yu","year":"2014","unstructured":"Yu, H. et al. Serum concentrations of cytokines in infants with retinopathy of prematurity. Apmis 122, 818\u2013823 (2014).","journal-title":"Apmis"},{"key":"7394_CR38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.earlhumdev.2016.09.008","volume":"102","author":"R Liegl","year":"2016","unstructured":"Liegl, R., L\u00f6fqvist, C., Hellstr\u00f6m, A. & Smith, L. E. IGF-1 in retinopathy of prematurity, a CNS neurovascular disease. Early Hum. Dev. 102, 13\u201319 (2016).","journal-title":"Early Hum. Dev."},{"key":"7394_CR39","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/MOL.0000000000000599","volume":"30","author":"D Struik","year":"2019","unstructured":"Struik, D., Dommerholt, M. B. & Jonker, J. W. Fibroblast growth factors in control of lipid metabolism: from biological function to clinical application. Curr. Opin. Lipido. 30, 235\u2013243 (2019).","journal-title":"Curr. Opin. Lipido."},{"key":"7394_CR40","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ecl.2012.04.017","volume":"41","author":"DR Clemmons","year":"2012","unstructured":"Clemmons, D. R. Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes. Endocrinol. Metab. Clin. North Am. 41, 425\u2013443 (2012).","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"7394_CR41","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/s41574-020-0386-0","volume":"16","author":"L Geng","year":"2020","unstructured":"Geng, L., Lam, K. S. L. & Xu, A. The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic. Nat. Rev. Endocrinol. 16, 654\u2013667 (2020).","journal-title":"Nat. Rev. Endocrinol."},{"key":"7394_CR42","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.cmet.2017.03.005","volume":"25","author":"LD BonDurant","year":"2017","unstructured":"BonDurant, L. D. et al. FGF21 Regulates Metabolism Through Adipose-Dependent and -Independent Mechanisms. Cell Metab. 25, 935\u2013944.e934 (2017).","journal-title":"Cell Metab."},{"key":"7394_CR43","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.bbadis.2016.05.002","volume":"1862","author":"Z Fu","year":"2016","unstructured":"Fu, Z., Gong, Y., L\u00f6fqvist, C., Hellstr\u00f6m, A. & Smith, L. E. Review: adiponectin in retinopathy. Biochim. Biophys. Acta 1862, 1392\u20131400 (2016).","journal-title":"Biochim. Biophys. Acta"},{"key":"7394_CR44","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/0003-9861(81)90488-4","volume":"211","author":"SC Frost","year":"1981","unstructured":"Frost, S. C. & Wells, M. A. A comparison of the utilization of medium and long-chain fatty acids for oxidation and ketogenesis in the suckling rat: In vivo and in vitro studies. Arch. Biochem. Biophys. 211, 537\u2013546 (1981).","journal-title":"Arch. Biochem. Biophys."},{"key":"7394_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111239","volume":"40","author":"B Zhou","year":"2022","unstructured":"Zhou, B. et al. Central FGF21 production regulates memory but not peripheral metabolism. Cell Rep. 40, 111239 (2022).","journal-title":"Cell Rep."},{"key":"7394_CR46","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.cmet.2010.02.001","volume":"11","author":"E Hondares","year":"2010","unstructured":"Hondares, E. et al. Hepatic FGF21 expression is induced at birth via PPARalpha in response to milk intake and contributes to thermogenic activation of neonatal brown fat. Cell Metab. 11, 206\u2013212 (2010).","journal-title":"Cell Metab."},{"key":"7394_CR47","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s42255-021-00354-2","volume":"3","author":"KH Flippo","year":"2021","unstructured":"Flippo, K. H. & Potthoff, M. J. Metabolic Messengers: FGF21. Nat. Metab. 3, 309\u2013317 (2021).","journal-title":"Nat. Metab."},{"key":"7394_CR48","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Garza, \u00da. et al. Fibroblast Growth Factor 21 and the Adaptive Response to Nutritional Challenges. Int. J. Mol. Sci. 20, 4692 (2019).","DOI":"10.3390\/ijms20194692"},{"key":"7394_CR49","doi-asserted-by":"crossref","unstructured":"Maida, A. et al. A liver stress-endocrine nexus promotes metabolic integrity during dietary protein dilution. J. Clin. Invest. 126, 3263\u20133278 (2022).","DOI":"10.1172\/JCI85946"},{"key":"7394_CR50","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1016\/j.molmet.2017.09.006","volume":"6","author":"S Olivares","year":"2017","unstructured":"Olivares, S. & Henkel, A. S. Induction of fibroblast growth factor 21 does not require activation of the hepatic X-box binding protein 1 in mice. Mol. Metab. 6, 1616\u20131624 (2017).","journal-title":"Mol. Metab."},{"key":"7394_CR51","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1042\/BJ20111748","volume":"443","author":"AL De Sousa-Coelho","year":"2012","unstructured":"De Sousa-Coelho, A. L., Marrero, P. F. & Haro, D. Activating transcription factor 4-dependent induction of FGF21 during amino acid deprivation. Biochem J. 443, 165\u2013171 (2012).","journal-title":"Biochem J."},{"key":"7394_CR52","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.cell.2015.05.019","volume":"161","author":"EJ O\u2019Brien","year":"2015","unstructured":"O\u2019Brien, E. J., Monk, J. M. & Palsson, B. O. Using Genome-scale Models to Predict Biological Capabilities. Cell 161, 971\u2013987 (2015).","journal-title":"Cell"},{"key":"7394_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-63235-w","volume":"10","author":"S Khodaee","year":"2020","unstructured":"Khodaee, S., Asgari, Y., Totonchi, M. & Karimi-Jafari, M. H. iMM1865: A New Reconstruction of Mouse Genome-Scale Metabolic Model. Sci. Rep. 10, 6177 (2020).","journal-title":"Sci. Rep."},{"key":"7394_CR54","doi-asserted-by":"publisher","first-page":"D614","DOI":"10.1093\/nar\/gky992","volume":"47","author":"A Noronha","year":"2019","unstructured":"Noronha, A. et al. The Virtual Metabolic Human database: integrating human and gut microbiome metabolism with nutrition and disease. Nucleic Acids Res. 47, D614\u2013D624 (2019).","journal-title":"Nucleic Acids Res."},{"key":"7394_CR55","doi-asserted-by":"publisher","first-page":"e30822","DOI":"10.1371\/journal.pone.0030822","volume":"7","author":"I Osorio-Paz","year":"2012","unstructured":"Osorio-Paz, I., Sanchez-Chavez, G. & Salceda, R. Control of glycogen content in retina: allosteric regulation of glycogen synthase. PLoS One 7, e30822 (2012).","journal-title":"PLoS One"},{"key":"7394_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.106777","volume":"26","author":"A Inague","year":"2023","unstructured":"Inague, A. et al. Oxygen-induced pathological angiogenesis promotes intense lipid synthesis and remodeling in the retina. iScience 26, 106777 (2023).","journal-title":"iScience"},{"key":"7394_CR57","doi-asserted-by":"publisher","first-page":"e2128771","DOI":"10.1001\/jamanetworkopen.2021.28771","volume":"4","author":"A Hellstr\u00f6m","year":"2021","unstructured":"Hellstr\u00f6m, A. et al. Association of Docosahexaenoic Acid and Arachidonic Acid Serum Levels With Retinopathy of Prematurity in Preterm Infants. JAMA Netw. Open 4, e2128771 (2021).","journal-title":"JAMA Netw. Open"},{"key":"7394_CR58","doi-asserted-by":"publisher","first-page":"H1112","DOI":"10.1152\/ajpheart.00620.2015","volume":"309","author":"C Beauloye","year":"2015","unstructured":"Beauloye, C., Horman, S. & Bertrand, L. Even is better than odd: one fat may conceal another. Am. J. Physiol. Heart Circ. Physiol. 309, H1112\u2013H1114 (2015).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"7394_CR59","doi-asserted-by":"publisher","first-page":"598760","DOI":"10.3389\/fgene.2020.598760","volume":"11","author":"E Sklirou","year":"2020","unstructured":"Sklirou, E., Alodaib, A. N., Dobrowolski, S. F., Mohsen, A. A. & Vockley, J. Physiological Perspectives on the Use of Triheptanoin as Anaplerotic Therapy for Long Chain Fatty Acid Oxidation Disorders. Front Genet 11, 598760 (2020).","journal-title":"Front Genet"},{"key":"7394_CR60","doi-asserted-by":"publisher","first-page":"H1157","DOI":"10.1152\/ajpheart.00298.2015","volume":"309","author":"M Kajimoto","year":"2015","unstructured":"Kajimoto, M. et al. Differential effects of octanoate and heptanoate on myocardial metabolism during extracorporeal membrane oxygenation in an infant swine model. Am. J. Physiol. Heart Circ. Physiol. 309, H1157\u2013H1165 (2015).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"7394_CR61","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s10545-006-0320-1","volume":"29","author":"H Brunengraber","year":"2006","unstructured":"Brunengraber, H. & Roe, C. R. Anaplerotic molecules: Current and future. J. Inherit. Metab. Dis. 29, 327\u2013331 (2006).","journal-title":"J. Inherit. Metab. Dis."},{"key":"7394_CR62","doi-asserted-by":"publisher","first-page":"5928","DOI":"10.1523\/JNEUROSCI.23-13-05928.2003","volume":"23","author":"D Ebert","year":"2003","unstructured":"Ebert, D., Haller, R. G. & Walton, M. E. Energy contribution of octanoate to intact rat brain metabolism measured by 13C nuclear magnetic resonance spectroscopy. J. Neurosci. 23, 5928\u20135935 (2003).","journal-title":"J. Neurosci."},{"key":"7394_CR63","doi-asserted-by":"crossref","unstructured":"Tan, K. N., McDonald, T. S. & Borges, K. in Bioactive Nutraceuticals and Dietary Supplements in Neurological and Brain Disease (eds. R.R. Watson & V.R. Preedy) 461\u2013473 (Academic Press, 2015).","DOI":"10.1016\/B978-0-12-411462-3.00048-5"},{"key":"7394_CR64","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.ymgme.2015.10.005","volume":"116","author":"CR Roe","year":"2015","unstructured":"Roe, C. R. & Brunengraber, H. Anaplerotic treatment of long-chain fat oxidation disorders with triheptanoin: Review of 15 years Experience. Mol. Genet Metab. 116, 260\u2013268 (2015).","journal-title":"Mol. Genet Metab."},{"key":"7394_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-017-0451-x","volume":"15","author":"EA Pearsall","year":"2017","unstructured":"Pearsall, E. A. et al. PPAR\u03b1 is essential for retinal lipid metabolism and neuronal survival. BMC Biol. 15, 113 (2017).","journal-title":"BMC Biol."},{"key":"7394_CR66","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3389\/fphys.2019.00419","volume":"10","author":"C Tezze","year":"2019","unstructured":"Tezze, C., Romanello, V. & Sandri, M. FGF21 as Modulator of Metabolism in Health and Disease. Front. Physiol. 10, 419 (2019).","journal-title":"Front. Physiol."},{"key":"7394_CR67","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev-physiol-021115-105339","volume":"78","author":"FM Fisher","year":"2016","unstructured":"Fisher, F. M. & Maratos-Flier, E. Understanding the Physiology of FGF21. Annu. Rev. Physiol. 78, 223\u2013241 (2016).","journal-title":"Annu. Rev. Physiol."},{"key":"7394_CR68","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.cmet.2023.11.010","volume":"36","author":"C Singh","year":"2024","unstructured":"Singh, C. et al. ChREBP is activated by reductive stress and mediates GCKR-associated metabolic traits. Cell Metab. 36, 144\u2013158.e147 (2024).","journal-title":"Cell Metab."},{"key":"7394_CR69","doi-asserted-by":"publisher","first-page":"eabo1857","DOI":"10.1126\/scisignal.abo1857","volume":"15","author":"J Liu","year":"2022","unstructured":"Liu, J. et al. The omega-3 hydroxy fatty acid 7(S)-HDHA is a high-affinity PPAR\u03b1 ligand that regulates brain neuronal morphology. Sci. Signal. 15, eabo1857 (2022).","journal-title":"Sci. Signal."},{"key":"7394_CR70","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2337\/db11-0413","volume":"62","author":"Y Chen","year":"2012","unstructured":"Chen, Y. et al. Therapeutic Effects of PPAR\u03b1 Agonists on Diabetic Retinopathy in Type 1 Diabetes Models. Diabetes 62, 261\u2013272 (2012).","journal-title":"Diabetes"},{"key":"7394_CR71","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1017\/S0007114508043389","volume":"101","author":"G Ventura","year":"2009","unstructured":"Ventura, G. et al. Overexpression of ornithine aminotransferase: consequences on amino acid homeostasis. Br. J. Nutr. 101, 843\u2013851 (2009).","journal-title":"Br. J. Nutr."},{"key":"7394_CR72","first-page":"101","volume":"35","author":"LE Smith","year":"1994","unstructured":"Smith, L. E. et al. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol. Vis. Sci. 35, 101\u2013111 (1994).","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"7394_CR73","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s42003-022-03774-2","volume":"5","author":"VK Jidigam","year":"2022","unstructured":"Jidigam, V. K. et al. Neuronal Bmal1 regulates retinal angiogenesis and neovascularization in mice. Commun. Biol. 5, 792 (2022).","journal-title":"Commun. Biol."},{"key":"7394_CR74","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","volume":"37","author":"D Kim","year":"2019","unstructured":"Kim, D., Paggi, J. M., Park, C., Bennett, C. & Salzberg, S. L. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat. Biotechnol. 37, 907\u2013915 (2019).","journal-title":"Nat. Biotechnol."},{"key":"7394_CR75","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2013","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930 (2013).","journal-title":"Bioinformatics"},{"key":"7394_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2010-11-10-r106","volume":"11","author":"S Anders","year":"2010","unstructured":"Anders, S. & Huber, W. Differential expression analysis for sequence count data. Genome Biol. 11, R106 (2010).","journal-title":"Genome Biol."},{"key":"7394_CR77","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.202100170","volume":"22","author":"DE Haslam","year":"2022","unstructured":"Haslam, D. E. et al. Stability and reproducibility of proteomic profiles in epidemiological studies: comparing the Olink and SOMAscan platforms. Proteomics 22, e2100170 (2022).","journal-title":"Proteomics"},{"key":"7394_CR78","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41596-018-0098-2","volume":"14","author":"L Heirendt","year":"2019","unstructured":"Heirendt, L. et al. Creation and analysis of biochemical constraint-based models using the COBRA Toolbox v.3.0. Nat. Protoc. 14, 639\u2013702 (2019).","journal-title":"Nat. Protoc."},{"key":"7394_CR79","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ebiom.2019.04.046","volume":"43","author":"MP Pacheco","year":"2019","unstructured":"Pacheco, M. P. et al. Identifying and targeting cancer-specific metabolism with network-based drug target prediction. EBioMedicine 43, 98\u2013106 (2019).","journal-title":"EBioMedicine"},{"key":"7394_CR80","doi-asserted-by":"publisher","first-page":"e1000489","DOI":"10.1371\/journal.pcbi.1000489","volume":"5","author":"C Colijn","year":"2009","unstructured":"Colijn, C. et al. Interpreting expression data with metabolic flux models: predicting Mycobacterium tuberculosis mycolic acid production. PLoS Comput. Biol. 5, e1000489 (2009).","journal-title":"PLoS Comput. Biol."},{"key":"7394_CR81","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s00125-020-05309-y","volume":"64","author":"Y Tomita","year":"2021","unstructured":"Tomita, Y. et al. Vitreous metabolomics profiling of proliferative diabetic retinopathy. Diabetologia 64, 70\u201382 (2021).","journal-title":"Diabetologia"},{"key":"7394_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-11-489","volume":"11","author":"S Gudmundsson","year":"2010","unstructured":"Gudmundsson, S. & Thiele, I. Computationally efficient flux variability analysis. BMC Bioinforma. 11, 489 (2010).","journal-title":"BMC Bioinforma."},{"key":"7394_CR83","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/978-1-4939-6996-8_14","volume":"1609","author":"T Cajka","year":"2017","unstructured":"Cajka, T. & Fiehn, O. LC-MS-Based Lipidomics and Automated Identification of Lipids Using the LipidBlast In-Silico MS\/MS Library. Methods Mol. Biol. 1609, 149\u2013170 (2017).","journal-title":"Methods Mol. Biol."},{"key":"7394_CR84","doi-asserted-by":"publisher","first-page":"W388","DOI":"10.1093\/nar\/gkab382","volume":"49","author":"Z Pang","year":"2021","unstructured":"Pang, Z. et al. MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights. Nucleic Acids Res. 49, W388\u2013W396 (2021).","journal-title":"Nucleic Acids Res."},{"key":"7394_CR85","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/nprot.2011.319","volume":"6","author":"J Xia","year":"2011","unstructured":"Xia, J. & Wishart, D. S. Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst. Nat. Protoc. 6, 743\u2013760 (2011).","journal-title":"Nat. Protoc."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-07394-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-07394-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-07394-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T09:02:51Z","timestamp":1736413371000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-07394-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,9]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7394"],"URL":"https:\/\/doi.org\/10.1038\/s42003-024-07394-w","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,9]]},"assertion":[{"value":"17 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25"}}